These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18318651)

  • 1. Lipid implants as drug delivery systems.
    Kreye F; Siepmann F; Siepmann J
    Expert Opin Drug Deliv; 2008 Mar; 5(3):291-307. PubMed ID: 18318651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release mechanisms of cast lipid implants.
    Kreye F; Siepmann F; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):394-400. PubMed ID: 21352913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms.
    Guse C; Koennings S; Kreye F; Siepmann F; Goepferich A; Siepmann J
    Int J Pharm; 2006 May; 314(2):137-44. PubMed ID: 16503388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modeling of drug release from lipid dosage forms.
    Siepmann J; Siepmann F
    Int J Pharm; 2011 Oct; 418(1):42-53. PubMed ID: 21802501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cast lipid implants for controlled drug delivery: importance of the tempering conditions.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    J Pharm Sci; 2011 Aug; 100(8):3471-3481. PubMed ID: 21544819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implants.
    Schönbrodt T; Mohl S; Winter G; Reich G
    J Control Release; 2006 Aug; 114(2):261-7. PubMed ID: 16872710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release mechanisms of compressed lipid implants.
    Kreye F; Siepmann F; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MALDI-TOF MS imaging of controlled release implants.
    Kreye F; Hamm G; Karrout Y; Legouffe R; Bonnel D; Siepmann F; Siepmann J
    J Control Release; 2012 Jul; 161(1):98-108. PubMed ID: 22551600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Materials to clinical devices: technologies for remotely triggered drug delivery.
    Timko BP; Kohane DS
    Clin Ther; 2012 Nov; 34(11):S25-35. PubMed ID: 23149010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable implants for the sustained release of protein and peptide drugs.
    Agarwal P; Rupenthal ID
    Drug Discov Today; 2013 Apr; 18(7-8):337-49. PubMed ID: 23410799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmable implants--from pulsatile to controlled release.
    Guse C; Koennings S; Blunk T; Siepmann J; Goepferich A
    Int J Pharm; 2006 May; 314(2):161-9. PubMed ID: 16551497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implants for drug substance delivery].
    Blanchemain N; Siepmann F; Siepmann J
    Med Sci (Paris); 2017 Jan; 33(1):32-38. PubMed ID: 28120753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
    Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
    Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.